.Función:Bioinformatician/Data scientist interested in diagnostic and therapeutic microbiome applications of the microbiome in infectious diseases and cancerEmpresa:Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS)No de Plazas: 1Referencia:IRYCIS-PostDocPublicada el 9/12/2024Publicada hasta el 1/2/2025Tipo de Contrato:Sin especificarDedicación: Jornada completaRemuneración Bruta (euros/año): 32756Localidad:MadridProvincia: MadridDisponibilidad para viajar: Sin especificarFecha de Incorporación:Primer Trimestre 2025Fecha de Finalización: 2 añosNivel Académico:DoctorÁreas tecnológicas:A-031 BioinformáticaConocimientos de Informática:Proficiency in bioinformatics tools and programming languages commonly used in omics technologies (Python, R)Experience with high-throughput omics analyses and data interpretation related to the microbiome.Experience in multi-omics integration is highly desirable.Proficiency in (multivariate) statistical analysesOtros:We seek a highly motivated postdoctoral researcher with a strong background in bioinformatics and multi-omics analysis. The candidate will play a pivotal role in advancing our research lines in diagnostic and therapeutic microbiome applications of the microbiome in infectious diseases and cancer.Our current research is focused on the exploration of diagnostic markers derived from a multi omic analysis of the microbiome, with a special focus on tuberculosis and anal cancer. Additionally, we are investigating the microbiome's influence on immunotherapy responses in lung cancer following fecal microbiota transplants, and the unique immune responses in people with HIV exhibiting natural control.The Applied Microbiome group, a part of the Infectious Diseases Service of the Ramón y Cajal Hospital and to Research Area 2 of the Ramón y Cajal Institute for Health Research (IRYCIS), is a vibrant interdisciplinary team. Our research spans several critical areas, including strategies for HIV, the microbiome's role on HIV immunopathogenesis, diagnostic marker identification in HIV/AIDS, and the effects of HIV on aging and disease progression. Additionally, we are active in epidemiology, focusing on early HIV diagnosis and various clinical-epidemiological aspects of HIV, often in collaboration with international cohorts. In the field of cancer, we are exploring the microbiome for cancer diagnostic biomarkers and its potential to enhance immunotherapy treatments.We are proud to offer a dynamic and stimulating work environment with highly productive research lines and a strong emphasis on innovation and clinical translation. We work within an academic hospital setting and actively engaged in projects that bridge the gap between innovation, technology transfer, and clinical application. More detailed information about the group's activities can be found on the IRYCIS website.Gross Salary: 32